Jianfeng Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jianfeng Wu has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Chuanwu Xi
Department of Environmental Health Sciences, University of Michigan School Of Public Health, Ann Arbor, USA
3 shared publications - Andrew P. Sikkema
Epigenetics and RNA Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park , NC 27709
1 shared publication - Ashootosh Tripathi
Natural Products Discovery Core, Life Sciences Institute, University of Michigan, Ann Arbor, USA
1 shared publication - Betsy Foxman
Center for Molecular and Clinical Epidemiology of Infectious Diseases, Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI
1 shared publication - Brian Lee
Life Sciences Institute, University of Michigan, 210 Washtenaw Avenue, Ann Arbor, MI, 48109-2216, USA
1 shared publication - David H. Sherman
Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109, USA
1 shared publication
Latest Publications
- 10 October 2026
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 30 (11) , 517
Nanobubbles enhance the effects of low-concentration sodium hypochlorite on root canal irrigation
- 10 October 2026
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 30 (11) , 517
Nanobubbles enhance the effects of low-concentration sodium hypochlorite on root canal irrigation
- 21 June 2018
- Published by Wiley in ChemBioChem
- Vol. 19 (15) , 1595-1600
A Defined and Flexible Pocket Explains Aryl Substrate Promiscuity of the Cahuitamycin Starter Unit–Activating Enzyme CahJ
Cahuitamycins are biofilm inhibitors assembled by a convergent nonribosomal peptide synthetase pathway. Previous genetic analysis indicated that a discrete enzyme, CahJ, serves as a gatekeeper for cahuitamycin structural diversification. Here, the CahJ protein was probed structurally and functionally to guide the formation of new analogues by mutasynthetic studies. This analysis enabled the in vivo production of a new cahuitamycin congener through targeted precursor incorporation.
- 21 June 2018
- Published by Wiley in ChemBioChem
- Vol. 19 (15) , 1595-1600
A Defined and Flexible Pocket Explains Aryl Substrate Promiscuity of the Cahuitamycin Starter Unit–Activating Enzyme CahJ
Cahuitamycins are biofilm inhibitors assembled by a convergent nonribosomal peptide synthetase pathway. Previous genetic analysis indicated that a discrete enzyme, CahJ, serves as a gatekeeper for cahuitamycin structural diversification. Here, the CahJ protein was probed structurally and functionally to guide the formation of new analogues by mutasynthetic studies. This analysis enabled the in vivo production of a new cahuitamycin congener through targeted precursor incorporation.
- Open Access
- 27 June 2012
- Published by Springer Nature in BMC Research Notes
- Vol. 5 (1) , 332
Early development of bacterial community diversity in emergently placed urinary catheters
Approximately 25% of hospitalized patients have a urinary catheter, and catheter associated urinary tract infection is the most common nosocomial infection in the US, causing >1 million cases/year. However, the natural history of the biofilms that rapidly form on urinary catheters and lead to infection is not well described.
- 27 June 2012
- Published by Springer Nature in BMC Research Notes
- Vol. 5 (1) , 332
Open AccessEarly development of bacterial community diversity in emergently placed urinary catheters
Approximately 25% of hospitalized patients have a urinary catheter, and catheter associated urinary tract infection is the most common nosocomial infection in the US, causing >1 million cases/year. However, the natural history of the biofilms that rapidly form on urinary catheters and lead to infection is not well described.